Humana HUM releases its next round of earnings this Monday, August 1, 2011. Here's Benzinga's essential guide to Humana's second quarter earnings report.
Earnings and Revenue:
Based on estimates, investors are readying for a positive EPS reading of $2.07 per share and revenues of $9.32 billion. Whether the reported numbers beat or miss analysts' estimates, they will also be compared against last year's numbers for the same period, which were a profit of $2.11 per share on revenues of $8.65 billion. We'll have to wait for Monday to see if Humana reports a decline in EPS and a boost in revenue from the year-ago quarter, as analysts are predicting.
Here's how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q1 | Q4 | Q3 | Q2 |
EPS Estimate | $1.45 | $0.80 | $1.67 | $1.63 |
EPS Actual | $1.55 | $1.65 | $2.01 | $2.11 |
Stock Performance:
At last check, shares of Humana were trading at $79.10. Shares are up 45% year to date. For a full 12 months, the return has risen by 52%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.
- Long-term shareholders are already enjoying 12-month gains prior to the announcement
Average Stock Rating:
The average rating by analysts for Humana is a Moderate Buy. Over the past three months this rating's strength has declined slightly.
Competitors:
Looking for a sympathy stock to trade or interested in the performance of other companies in the same sector? Take a look at some of Humana's peers.
- Aetna AET: Moderate Buy with a $1.43 recent quarter EPS
- CIGNA CI: Hold with a $1.37 recent quarter EPS
- Health Net HNT: Hold with a $0.61 recent quarter EPS
- Triple-S Management (GTS): Hold with a $0.44 recent quarter EPS
The medical-HMO company's industry has seen price/earnings growth of 1.1% during the current fiscal year.
Finally, a description of the company's main areas of operation: Humana is a managed health care company that offers health and supplemental benefit products.
Take Action:
Now that you have reviewed all the numbers, be ready to move if the upcoming Humana earnings report has any surprises. Also, come back to Benzinga after the announcement for a full recap and a guide to your next steps.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.